First subcutaneous, once-monthly octreotide for treatment of acromegalyFor convenient self-administration with a pre-filled autoinjector penLUND, Sweden, ...

Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both ...

The details of the differential diagnosis between lymphocytic hypophysitis and pituitary adenoma are systematically described by Gutenberg et al.[3] Laboratory Evaluation ...

Among the 91 pituitary adenomas, 23 were growth hormone-secreting, 6 were prolactin-secreting, 5 were adrenocorticotropic hormone-secreting and 57 were nonfunctioning adenomas. All 34 functioning ...

Familial isolated pituitary adenomas are an increasingly recognized condition. This article reviews FIPA clinical characteristics, tumor pathology, and genetic findings.